Skip to main content
. 2015 Dec 15;192(12):1475–1482. doi: 10.1164/rccm.201505-1010OC

Table 2.

Sensitivity Analysis of NAC-associated Endpoint Risk after rs3750920, rs5743894, and rs35705950 Genotype Stratification*

SNP (Gene) Genotype Death/Transplant/Hosp/FVC Decline
Death/Transplant/Hosp
Death/Transplant/FVC Decline
HR (95% CI) P Value HR (95% CI) P Value HR (95% CI) P Value
rs3750920 (TOLLIP) CC 3.22 (0.79–13.16) 0.1 3.74 (0.35–39.80) 0.27 1.27 (0.21–7.55) 0.79
rs3750920 (TOLLIP) CT 0.76 (0.27–2.19) 0.62 0.45 (0.10–2.15) 0.32 0.63 (0.17–2.30) 0.48
rs3750920 (TOLLIP) TT 0.14 (0.02–0.83) 0.03 0.09 (0.01–0.76) 0.03
rs5743894 (TOLLIP) AA 1.67 (0.71–3.95) 0.24 1.43 (0.44–4.70) 0.56 1.68 (0.58–4.90) 0.34
rs5743894 (TOLLIP) AG/GG 0.33 (0.10–1.14) 0.08 0.21 (0.02–1.99) 0.18 0.18 (0.04–0.90) 0.04
rs35705950 (MUC5B) GG 2.02 (0.57–7.20) 0.28 1.25 (0.15–10.30) 0.84 3.72 (0.69–20.16) 0.13
rs35705950 (MUC5B) GT/TT 0.60 (0.27–1.35) 0.22 0.49 (0.15–1.58) 0.23 0.32 (0.11–0.94) 0.04

Definition of abbreviations: CI = confidence interval; Hosp = hospitalization; HR = hazard ratio; NAC = N-acetylcysteine; SNP = single-nucleotide polymorphism.

*

Models adjusted for age, sex, FVC (percentage predicted) and diffusion capacity of the lung for carbon monoxide (percentage predicted).

HR cannot be estimated owing to absence of events.